Stephanie Plaines - 31 Dec 2025 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Jinho Joo, Attorney-in-Fact
Issuer symbol
CLX
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 16:47:53 UTC
Previous filing
02 Oct 2025
Next filing
23 Jan 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Stephanie Plaines filed Form 4 for CLOROX CO /DE/ (CLX) on 05 Jan 2026."

Quick Takeaways

  • This page summarizes Stephanie Plaines's Form 4 filing for CLOROX CO /DE/ (CLX).
  • 3 reported transactions and 3 derivative rows are listed below.
  • Filing timestamp: 05 Jan 2026, 16:47.

What Changed

  • Previous filing in this sequence was filed on 02 Oct 2025.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Plaines Stephanie Director 1221 BROADWAY, OAKLAND By Jinho Joo, Attorney-in-Fact 05 Jan 2026 0001771330

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +63 +1.2% $0.000000 5,476 06 Nov 2025 Common Stock 63 Direct F1, F2, F3
transaction CLX Deferred Stock Units Award $0 +1,638 +30% $0.000000 7,114 31 Dec 2025 Common Stock 1,638 Direct F1, F3, F4
transaction CLX Deferred Stock Units Award $0 +273 +3.8% $0.000000 7,387 31 Dec 2025 Common Stock 273 Direct F1, F3, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1-for-1
F2 Deferred Stock Units acquired through dividend reinvestment during the fiscal year pursuant to the Independent Directors' Deferred Compensation Plan.
F3 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.
F4 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F5 Receipt of Deferred Stock Units in lieu of receipt of quarterly director's fees.

Sponsored